معرفی
Professor Peter MacCallum is a clinical academic at Queen Mary University of London and an honorary consultant haematologist at Barts Health NHS Trust. He leads the thrombosis service at St Bartholomew’s and the Royal London Hospitals, specializing in venous thromboembolism (VTE), cancer-associated thrombosis, and coagulation disorders. His research focuses on personalized VTE management, cancer-related thrombosis pathways, and thrombotic complications of medical conditions like COVID-19 and vaccine-induced thrombosis with thrombocytopenia.
He has led major studies including the ORANGE registry (bleeding outcomes on oral anticoagulants) and contributed to the GARFIELD-VTE global registry. His future plans involve collaborations on cancer-related coagulation pathways, addressing a significant mortality burden in cancer patients.
- Key Roles: Professor in Haematology, Honorary Consultant Haematologist
- Research Leadership: Chief Investigator (ORANGE study), National Co-ordinating Investigator (GARFIELD-VTE)
- Teaching: Mentor for medical students and doctoral candidates, including an MD(Res) student who completed her viva within 4 years despite pandemic challenges.
Publications span clinical outcomes of anticoagulants, cancer VTE therapies, and coagulation abnormalities in SARS-CoV-2 infection. He has authored chapters in major textbooks such as the Oxford Textbook of Medicine and Kumar and Clark’s Clinical Medicine.
